Key Takeaways
- State Street (STT) and U.S. Bancorp (USB) both delivered significant Q2 2026 earnings beats, driven by record revenues and expanding net interest margins.
- Abbott Laboratories (ABT) surpassed analyst expectations and raised its full-year EPS guidance to a range of $5.45 to $5.60, citing strong momentum in its medical device segment.
- Geopolitical tensions spiked as Yemen's Houthi movement reportedly prepares to shut the Bab el-Mandeb Strait, a critical waterway carrying 10–12% of global maritime trade.
- CXMT launched a massive $8.55 billion IPO on Shanghai’s STAR Market, with the retail portion reportedly 212 times oversubscribed, marking Asia's largest listing of 2026.
- Spot Gold prices fell nearly 1% to approximately $4,024/oz, continuing a short-term bearish trend despite maintaining long-term structural support.
Financial Sector: Record Revenues and Earnings Surprises
Major financial institutions reported robust second-quarter results on Thursday, signaling resilience in the banking sector. State Street (STT) posted an adjusted EPS of $3.65, handily beating the $3.33 estimate. The firm’s revenue climbed 17.4% year-over-year to $4.05 billion, supported by record Assets Under Management (AUM) of $6.28 trillion. Additionally, the company declared a 10% increase in its third-quarter common dividend.
U.S. Bancorp (USB) also outperformed, reporting record net revenue of $7.712 billion against expectations of $7.583 billion. The bank's net income rose 19.9% to $2.177 billion, with a diluted EPS of $1.35. Management highlighted 400 basis points of positive operating leverage and improved credit quality, as the net charge-off ratio fell to 0.53%.
Healthcare: Abbott Labs Raises Outlook
Abbott Laboratories (ABT) reported a strong second quarter, with net sales of $12.59 billion exceeding the $12.50 billion IBES estimate. The company’s adjusted EPS of $1.31 beat the consensus of $1.28. Growth was primarily led by the Medical Devices division, which saw sales of $5.85 billion, up 9.0% on a reported basis.
Following the strong performance, Abbott raised its full-year 2026 adjusted diluted EPS guidance to $5.45–$5.60, up from the previous range of $5.38–$5.58. CEO Robert B. Ford noted that the company expects this momentum to drive "accelerating sales and earnings growth" in the second half of the year.
Geopolitical Alert: Maritime Trade at Risk
Security concerns in the Middle East intensified following reports that Yemen's Houthis are preparing to shut the Bab el-Mandeb Strait. This strategic chokepoint connects the Red Sea to the Gulf of Aden and is vital for energy and cargo shipments between Europe and Asia. Analysts warn that a closure could force vessels to reroute around the Cape of Good Hope, drastically increasing shipping costs and potentially pushing oil prices toward $200 a barrel.
Simultaneously, Kuwait's air defenses were active on Thursday, responding to "hostile drone threats." The Kuwaiti General Staff confirmed interceptions and urged the public to follow safety instructions. These developments come amid broader regional instability and a reported expansion of military strikes in the area.
Commodities and IPOs: CXMT Hype and Gold Softness
In the capital markets, China's leading memory chipmaker, CXMT, is making waves with its 57.9 billion yuan ($8.55 billion) IPO. The retail portion of the offering was reportedly 212 times covered, reflecting massive investor appetite for China's semiconductor self-sufficiency play. The shares are scheduled to begin trading on the Shanghai STAR Market on July 27.
Meanwhile, Spot Gold faced downward pressure, falling to $4,024.39/oz. The decline is attributed to a "hawkish" tilt in Federal Reserve expectations and a dominant short-term bearish trend. Despite the daily drop, the metal remains more than 20% higher than its price one year ago, as central bank buying continues to provide a structural floor.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.